Related articles
-
NewsNo refrigeration needed for killer disease vaccine
Malaria kills more than half a million people every year, but a new vaccine is showing promise as it not only offers long-lasting strong protection but also inhibits transmission of malaria by mosquitos. The vaccine is predicted to be low cost and its cold-chain independence strongly enhances its deployability.
-
NewsDoes agriculture and climate affect feeding activities of soil animals?
An international research team has shown that soil animal communities have greater trophic diversity in agricultural ecosystems and in tropical regions. Animals that feed on microorganisms – such as nematodes, springtails and mites – had higher trophic diversity than those that feed on dead organic matter or live as predators.
-
NewsNew reactor design produces renewable methane from carbon dioxide
A new reactor design efficiently converts carbon dioxide and renewable electricity into methane while scaling the system up by roughly an order of magnitude. It demonstrated that microbial electrosynthesis systems can be expanded beyond laboratory-scale devices while maintaining high energy efficiency and methane production rates.
More from News
-
NewsProtists and bacteria form secret alliance to stop fusarium wilt
Scientists have uncovered how phagotrophic protists team up with beneficial bacteria to suppress watermelon Fusarium wilt. Through microbial sequencing and ecological network analysis, they found that nutrient imbalance disrupts these partnerships, allowing the fungal pathogen to spread.
-
NewsFrom Helicobacter pylori to the AMR crisis: our interview with JAM Microbiology in Health and Disease Lead Editor Liang Wang
We get to know Professor Liang Wang, who has just been appointed as new Lead Editor in Microbiology in Health and Disease at the Journal of Applied Microbiology.
-
NewsResearchers develop promising drug candidate for control and elimination of malaria
Researchers have developed a novel chemical compound that shows promise for the treatment and prevention of malaria, one of the world’s deadliest diseases. T111 has the potential to become a single-encounter malaria drug that would simplify treatment and prevent relapses that drive ongoing transmission.
No comments yet